Predicting the Severity of Lockdown-Induced Psychiatric Symptoms with Machine Learning.
COVID-19
anxiety
depression
machine learning
obsessive-compulsive disorder
prediction
Journal
Diagnostics (Basel, Switzerland)
ISSN: 2075-4418
Titre abrégé: Diagnostics (Basel)
Pays: Switzerland
ID NLM: 101658402
Informations de publication
Date de publication:
12 Apr 2022
12 Apr 2022
Historique:
received:
07
03
2022
revised:
07
04
2022
accepted:
10
04
2022
entrez:
23
4
2022
pubmed:
24
4
2022
medline:
24
4
2022
Statut:
epublish
Résumé
During the COVID-19 pandemic, an increase in the incidence of psychiatric disorders in the general population and an increase in the severity of symptoms in psychiatric patients have been reported. Anxiety and depression symptoms are the most commonly observed during large-scale dramatic events such as pandemics and wars, especially when these implicate an extended lockdown. The early detection of higher risk clinical and non-clinical individuals would help prevent the new onset and/or deterioration of these symptoms. This in turn would lead to the implementation of public policies aimed at protecting vulnerable populations during these dramatic contingencies, therefore optimising the effectiveness of interventions and saving the resources of national healthcare systems. We used a supervised machine learning method to identify the predictors of the severity of psychiatric symptoms during the Italian lockdown due to the COVID-19 pandemic. Via a case study, we applied this methodology to a small sample of healthy individuals, obsessive-compulsive disorder patients, and adjustment disorder patients. Our preliminary results show that our models were able to predict depression, anxiety, and obsessive-compulsive symptoms during the lockdown with up to 92% accuracy based on demographic and clinical characteristics collected before the pandemic. The presented methodology may be used to predict the psychiatric prognosis of individuals under a large-scale lockdown and thus supporting the related clinical decisions.
Identifiants
pubmed: 35454005
pii: diagnostics12040957
doi: 10.3390/diagnostics12040957
pmc: PMC9025309
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Proc Natl Acad Sci U S A. 2021 Mar 2;118(9):
pubmed: 33571107
Int J Environ Res Public Health. 2021 Jun 30;18(13):
pubmed: 34209311
Arch Gen Psychiatry. 1989 Nov;46(11):1006-11
pubmed: 2684084
Am J Psychiatry. 1998 Jan;155(1):102-8
pubmed: 9433346
IEEE Trans Neural Netw Learn Syst. 2021 Feb 19;PP:
pubmed: 33606639
Front Psychiatry. 2020 Aug 07;11:790
pubmed: 32848952
J Int Med Res. 2020 May;48(5):300060520922679
pubmed: 32458715
Annu Rev Clin Psychol. 2018 May 7;14:91-118
pubmed: 29401044
Diagnostics (Basel). 2021 Mar 30;11(4):
pubmed: 33808100
Brain Behav Immun. 2020 Jul;87:40-48
pubmed: 32298802
Eur Psychiatry. 2020 Sep 28;63(1):e87
pubmed: 32981568
J Affect Disord. 2014 Apr;158:139-47
pubmed: 24655778
Br J Psychiatry. 2020 Sep;217(3):475-476
pubmed: 32412401
Clin Psychol Psychother. 2020 Jul;27(4):611-620
pubmed: 32196815
Biomed Hub. 2017 Aug 05;2(2):1-5
pubmed: 31988910
Gen Psychiatr. 2020 Apr 1;33(2):e100216
pubmed: 32363326
Psychol Med. 2021 Apr;51(6):1054-1056
pubmed: 32423496
Diagnostics (Basel). 2021 Nov 05;11(11):
pubmed: 34829400
Assessment. 2002 Dec;9(4):361-72
pubmed: 12462756
Curr Psychiatry Rep. 2021 Oct 6;23(11):71
pubmed: 34613498
Nat Rev Dis Primers. 2019 Aug 1;5(1):52
pubmed: 31371720
Brain Behav Immun. 2020 Jul;87:100-106
pubmed: 32353518
Int J Environ Res Public Health. 2019 Jul 16;16(14):
pubmed: 31315203